chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, SARS-CoV-2 test
Clinical narrative: Sore arm; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 59 year-old female patient received bnt162b2 (BNT162B2), administered in arm left, administration date 24Apr2021 12:15 (Lot number: ER8731) at the age of 59 years as dose 1, single for covid-19 immunisation. Relevant medical history included: "Verbatim: Uterine cancer" (unspecified if ongoing), notes: Verbatim: Uterine cancer, Had about 30 years ago; "Covid 19 virus", start date: Mar2020 (unspecified if ongoing), notes: she did have the Covid 19 virus in Mar2020; "headache" (unspecified if ongoing). Concomitant medication(s) included: TYLENOL taken for headache. The following information was reported: PAIN IN EXTREMITY (non-serious) with onset 2021, outcome "unknown", described as "Sore arm". Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were taken as a result of pain in extremity with Tylenol. Additional information: Patient did not have any AE(s) require a visit to Emergency Room/Physician Office.  Follow-up attempts completed. No further information expected.
Sex: M
Vaccine: COVID19
Symptoms: Back pain, Diarrhoea, Gastroenteritis viral, Neck pain, Vomiting
Clinical narrative: Back was hurting; Back was hurting him terribly; Pain moved in from the front of his body to his neck; Back was hurting; Back was hurting him terribly; Pain moved in from the front of his body to his neck; Developed stomach virus and he started throwing up; Developed stomach virus and he started throwing up; Diarrhea; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP).  A male patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose 2, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (1ST DOSE), for COVID-19 immunization. The following information was reported: BACK PAIN (non-serious), NECK PAIN (non-serious), outcome "not recovered" and all described as "Back was hurting; Back was hurting him terribly; Pain moved in from the front of his body to his neck"; GASTROENTERITIS VIRAL (non-serious), VOMITING (non-serious), outcome "recovered" and all described as "Developed stomach virus and he started throwing up"; DIARRHOEA (non-serious), outcome "recovered", described as "Diarrhea". Therapeutic measures were taken as a result of back pain, neck pain, gastroenteritis viral, vomiting, diarrhoea.  Additional information: Three weeks ago, patient got vaccine at 9 o' clock in the morning and at 9 o' clock at night patient stood up and said his back was hurting. The next day, patient stayed mad all day long and he said that his back was hurting him terribly. Patient stayed mad and then the pain moved in from the front of his body to his neck and it lasted for about three or four days and then patient seems to be better but within another day, he developed stomach virus and he started throwing up and had diarrhea. It's had been two or three days and when that was over, the back pain was back and so patient had been taking some kind of anti-inflammatory (Unspecified Medication) and it was not really helping. It seems like patient was pretty much in and out ever since and that was his second dose. Reporter queried for Is that a side effect that anybody had reported or not. Reporter stated that trying to figure out what is wrong with him.  No follow-up attempts are possible. No further information is expected.
Age: 57.0
Sex: M
Vaccine: COVID19
Symptoms: Headache, Myalgia, Nasopharyngitis
Clinical narrative: freezing, absolutely freezing, he couldn't get warm; all his muscles ached; major headache; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 57 year-old male patient received bnt162b2 (BNT162B2), administered in arm left, administration date 06May2021 11:15 (Lot number: EW0175) at the age of 57 years as dose 2, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (DOSE 1, Lot: EW0162 , Time- 09:30, Anatomical location: Left arm), administration date: 15Apr2021, for COVID-19 immunization. The following information was reported: NASOPHARYNGITIS (non-serious) with onset 15May2021 19:00, outcome "recovered" (16May2021), described as "freezing, absolutely freezing, he couldn't get warm"; MYALGIA (non-serious) with onset 15May2021 19:00, outcome "recovered" (16May2021), described as "all his muscles ached"; HEADACHE (non-serious) with onset 15May2021 19:00, outcome "recovered" (16May2021), described as "major headache".  Additional information: The patient experienced AE 9.5 days after his second dose. Nasopharyngitis and myalgia lasted for all by about 12 hours after onset and major headache lasted about 24 hours after onset. No Investigation Assessment done. No vaccines administered on the same date of the Pfizer suspect. No prior vaccinations (within 4 weeks) was administered. No AE following prior vaccinations.  No follow-up attempts are possible. No further information is expected.
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Diarrhoea, Fatigue, Headache, Illness
Clinical narrative: not feeling well; she was very ill; Diarrhea; Vomiting; Chills; Headache; extremely tired, wiped out; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 67 year-old female patient received bnt162b2 (BNT162B2), administration date 05May2021 (Batch/Lot number: unknown) at the age of 67 years as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: ILLNESS (non-serious) with onset 17May2021, outcome "recovered" (May2021), described as "she was very ill"; DIARRHOEA (non-serious) with onset 17May2021, outcome "recovered" (May2021), described as "Diarrhea"; VOMITING (non-serious) with onset 17May2021, outcome "recovered" (May2021), described as "Vomiting"; CHILLS (non-serious) with onset 17May2021, outcome "recovered" (May2021), described as "Chills"; HEADACHE (non-serious) with onset 17May2021, outcome "recovered" (May2021), described as "Headache"; FATIGUE (non-serious) with onset 17May2021, outcome "recovered" (May2021), described as "extremely tired, wiped out"; MALAISE (non-serious), outcome "unknown", described as "not feeling well".  Additional Information: The patient received COVID-19 vaccine on 05May2021 and 12 days later she was very ill. She says she is better now. She says she was experiencing diarrhea, vomiting, chills, a headache, and she was extremely tired, wiped out.the report at this time. She says you could have a reaction 10 to 14 days later. She says her main concern is should she get the second shot. The patient asks how much longer this will be and that she has to go to the bathroom. She apologizes and says she is not feeling well.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Malaise, Vomiting
Clinical narrative: not feeling well; she was very ill; Diarrhea; Vomiting; Chills; Headache; extremely tired, wiped out; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 67 year-old female patient received bnt162b2 (BNT162B2), administration date 05May2021 (Batch/Lot number: unknown) at the age of 67 years as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: ILLNESS (non-serious) with onset 17May2021, outcome "recovered" (May2021), described as "she was very ill"; DIARRHOEA (non-serious) with onset 17May2021, outcome "recovered" (May2021), described as "Diarrhea"; VOMITING (non-serious) with onset 17May2021, outcome "recovered" (May2021), described as "Vomiting"; CHILLS (non-serious) with onset 17May2021, outcome "recovered" (May2021), described as "Chills"; HEADACHE (non-serious) with onset 17May2021, outcome "recovered" (May2021), described as "Headache"; FATIGUE (non-serious) with onset 17May2021, outcome "recovered" (May2021), described as "extremely tired, wiped out"; MALAISE (non-serious), outcome "unknown", described as "not feeling well".  Additional Information: The patient received COVID-19 vaccine on 05May2021 and 12 days later she was very ill. She says she is better now. She says she was experiencing diarrhea, vomiting, chills, a headache, and she was extremely tired, wiped out.the report at this time. She says you could have a reaction 10 to 14 days later. She says her main concern is should she get the second shot. The patient asks how much longer this will be and that she has to go to the bathroom. She apologizes and says she is not feeling well.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Pain
Clinical narrative: This is a spontaneous report received from a contactable consumer or other non-HCP (patient). A female patient received the 2nd dose of BNT162B2 (Pfizer-BioNTech COVID-19 vaccine, batch/lot# unknown), May 2021, single dose, for COVID-19 immunisation. Medical history included stomach surgery, start date: 2017 (unspecified if ongoing). The patient's concomitant medications not reported. Vaccination history included the 1st dose of BNT162B2 (Pfizer-BioNTech COVID-19 vaccine), for immunization. The patient experienced pain (having a lot of pain on right-side), onset May 2021, with outcome of unknown. Additional information: Patient had got the second vaccine on Monday. She has had lot of pain on her right-side. She had stomach surgery. They removed half her stomach in 2017. She can't tell if the pain is in her stomach, back or breast. It started on Wednesday. The first one was on Apr 14, 2021. No follow-up attempts possible. Information about batch/lot number cannot be obtained. No further information expected.
Sex: F
Vaccine: COVID19
Symptoms: Decreased appetite, Pain in extremity
Clinical narrative: she noticed that her daughter only ate about half of her dinner last night (decreased appetite); her arm hurting; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the parent.  A 16 year-old female patient received bnt162b2 (BNT162B2), administration date 17May2021 (Batch/Lot number: unknown) as dose number unknown, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DECREASED APPETITE (non-serious) with onset 2021, outcome "unknown", described as "she noticed that her daughter only ate about half of her dinner last night (decreased appetite)"; PAIN IN EXTREMITY (non-serious) with onset 2021, outcome "unknown", described as "her arm hurting". that her daughter only ate about half of her dinner last night (decreased appetite), she complained of her arm hurting and that her daughter is still sleeping at this time. The caller wants to know if there are any other side effects that she should be concerned about for her 16 year old daughter who received the Pfizer COVID-19 vaccine yesterday that are different from side effects for adults.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 49.0
Sex: M
Vaccine: COVID19
Symptoms: Headache
Clinical narrative: light mild headache; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 49 year-old male patient received bnt162b2 (BNT162B2), administered in arm right, administration date 01Apr2021 (Lot number: EP7533) at the age of 49 years as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: HEADACHE (non-serious) with onset Apr2021, outcome "recovered" (Apr2021), described as "light mild headache". Therapeutic measures were taken as a result of headache.  Additional information: The patient took the first Pfizer shot on 01Apr2021. The patient had a little mild side effect, like a slight headache, nothing at all. The patient took Aspirin and Tylenol and was fine.  No follow-up attempts are possible. No further information is expected.
Age: 45.0
Sex: F
Vaccine: COVID19
Symptoms: Rectal discharge
Clinical narrative: I've had two incidents of rectal discharge since receiving the second shot.; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 45 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 13May2021 10:30 (Lot number: EW0167) at the age of 45 years as dose 2, single for covid-19 immunisation. Relevant medical history included: "Systemic Lupus Erythematosus" (unspecified if ongoing), notes: Verbatim: Systemic Lupus Erythematosus. Concomitant medication(s) included: VIMPAT. Past drug history included: Penicillin, reaction(s): "allergy", notes: known allergies : Penicillin (reaction when I was a baby, haven't had again). Vaccination history included: Bnt162b2 (Lot number: ER8735, Administration time: 01:30 PM, Dose number: 1, Vaccine location: Left arm), administration date: 21Apr2021, when the patient was 45 years old, for COVID-19 Immunization. The following information was reported: RECTAL DISCHARGE (non-serious) with onset 14May2021, outcome "unknown", described as "I've had two incidents of rectal discharge since receiving the second shot.". Therapeutic measures were not taken as a result of rectal discharge.  Additional information: The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Other medications received within 2 weeks of vaccination included Vimpat. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. It was reported that the patient had two incidents of rectal discharge since receiving the second shot. The first the day after and the second 4 days later. There was no Hospitalization Prolonged.  Follow-up attempts completed. No further information expected.
Age: 41.0
Sex: M
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: left arm burning post injection; This is a spontaneous report received from a from a contactable nurse.  A 41 year-old male patient received bnt162b2 (BNT162B2), intramuscular, administered in arm left, administration date 05May2021 13:15 (Lot number: EW0153) at the age of 41 years as dose 2, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (Dose 1, single), for COVID-19 Immunization, reaction(s): "Arm redness/pain/burning", "Arm redness/pain/burning", "Arm redness/pain/burning".  The following information was reported: VACCINATION SITE PAIN (non-serious) with onset 05May2021 13:15, outcome "unknown", described as "left arm burning post injection". Therapeutic measures were not taken as a result of vaccination site pain.  Additional information: It was unknown if the patient received any other vaccines within 4 weeks prior to the COVID vaccine. It was unknown if the patient received any medications within 2 weeks of vaccination. Prior to vaccination, it was unknown whether the patient was diagnosed with COVID-19 or not. Since the vaccination, it was unknown whether the patient has been tested for COVID-19 or not. It was reported that patient had left arm burning post injection; states same reaction with first dose. Arm redness/pain/burning.   Follow-up attempts completed. No further information is expected.
Age: 57.0
Sex: M
Vaccine: COVID19
Symptoms: Dizziness, Fatigue
Clinical narrative: light headed; tired; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A 57 year-old male patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) at the age of 57 years as dose 1, single for covid-19 immunisation. Relevant medical history included: "Heart disease" (unspecified if ongoing), notes: Verbatim: Heart disease. The patient's concomitant medications were not reported. The following information was reported: DIZZINESS (non-serious), outcome "unknown", described as "light headed"; FATIGUE (non-serious), outcome "unknown", described as "tired".  Additional information: It was reported that, the patient had received first dose of the Pfizer COVID 19 vaccine and was observed for 15 minutes and he felt fine. When patient went home then he started feeling light headed and tired.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Sex: U
Vaccine: COVID19
Symptoms: Limb discomfort, Malaise, Migraine, Nasopharyngitis, Pain in extremity
Clinical narrative: Little severe migraine headache; I have gaining weight; Little severe migraine headache; I have gaining weight; My arm is really sore; I am not able to raise that up; My arm is really sore; I am not able to raise that up; I am not feeling really well and kind of under weather; also I am having a little cold; I am not feeling really well and kind of under weather; also I am having a little cold; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A patient (no qualifiers provided) received bnt162b2 (BNT162B2), administration date 14May2021 (Batch/Lot number: unknown) as dose number unknown, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: MIGRAINE (non-serious), WEIGHT INCREASED (non-serious), outcome "unknown" and all described as "Little severe migraine headache; I have gaining weight"; LIMB DISCOMFORT (non-serious), PAIN IN EXTREMITY (non-serious), outcome "unknown" and all described as "My arm is really sore; I am not able to raise that up"; NASOPHARYNGITIS (non-serious), MALAISE (non-serious), outcome "unknown" and all described as "I am not feeling really well and kind of under weather; also I am having a little cold".  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Sex: U
Vaccine: COVID19
Symptoms: Weight increased
Clinical narrative: Little severe migraine headache; I have gaining weight; Little severe migraine headache; I have gaining weight; My arm is really sore; I am not able to raise that up; My arm is really sore; I am not able to raise that up; I am not feeling really well and kind of under weather; also I am having a little cold; I am not feeling really well and kind of under weather; also I am having a little cold; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A patient (no qualifiers provided) received bnt162b2 (BNT162B2), administration date 14May2021 (Batch/Lot number: unknown) as dose number unknown, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: MIGRAINE (non-serious), WEIGHT INCREASED (non-serious), outcome "unknown" and all described as "Little severe migraine headache; I have gaining weight"; LIMB DISCOMFORT (non-serious), PAIN IN EXTREMITY (non-serious), outcome "unknown" and all described as "My arm is really sore; I am not able to raise that up"; NASOPHARYNGITIS (non-serious), MALAISE (non-serious), outcome "unknown" and all described as "I am not feeling really well and kind of under weather; also I am having a little cold".  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Ear pain, Pain in extremity, Vaccination site pain
Clinical narrative: Sore arm/Hers was kind of at the injection site; Her entire arm was radiating with pain, more intense; Pain that was under ear extending to palm of hand; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A female patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: VACCINATION SITE PAIN (non-serious), outcome "recovered", described as "Sore arm/Hers was kind of at the injection site"; PAIN IN EXTREMITY (non-serious), outcome "recovered", described as "Her entire arm was radiating with pain, more intense"; EAR PAIN (non-serious), outcome "recovered", described as "Pain that was under ear extending to palm of hand".  Additional Information: The patient had a sore arm just after her vaccination. She stated that it was the Pfizer Covid-19 vaccine because her, her husband, and children all did their first dose and have not done their second dose yet. The patient clarified that her sore arm was at the injection site. The next day, when she woke up, she had pain that was under her ear and it extended all the way to the palm of her hand. Her entire arm was radiating with pain, more intense than she ever felt with the tetanus. The very next day, nothing, zero. She thought she would get up in horrible pain and did not-it was just gone.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Pain in extremity, Paraesthesia
Clinical narrative: Dizzy spells; Tingling going down that side and into her leg; arm didn't hurt much; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 58 year-old female patient received bnt162b2 (BNT162B2), administered in arm left, administration date 30Apr2021 14:30 (Batch/Lot number: unknown) at the age of 58 years as dose 1, single for covid-19 immunisation. The patient had no relevant medical history. There were no concomitant medications. The following information was reported: DIZZINESS (non-serious) with onset May2021, outcome "not recovered", described as "Dizzy spells"; PARAESTHESIA (non-serious) with onset 30Apr2021, outcome "recovering", described as "Tingling going down that side and into her leg"; PAIN IN EXTREMITY (non-serious) with onset 2021, outcome "unknown", described as "arm didn't hurt much". Therapeutic measures were not taken as a result of dizziness, paraesthesia, pain in extremity. Additional information: Patient Age at Time of Vaccination was reported as 58 years. She got the COVID-19 vaccine about 3.5 weeks ago, the first shot. It was fine. Her arm did not hurt much. On the side a few hours later she had a tingling going down that side and into her leg. It took a while over week for this side effect to kick in. She was wondering if other people have had it. She had been having it ever since. Vaccination facility type was reported as Hospital. She was having dizziness. It is not total vertigo, but it was dizzy spells. It is unnerving. She had never had it before. A friend sent her a website saying it was a possible side effect. The dizziness had been for 10 days. It was sporadic. It came and went. She is a little dizzy right now. The dizziness started a little over a week after getting the vaccine, or maybe 10 days.  The tingling was prior to that. The dizzy spells are persisting. She thought they had improved for 1 to 2 days, but they are back again. They are consistent. One day it was not as bad and she went on a long walk, but she did not feel like she could do it the day before or after. Not so much tingling now. She had a little bit, but not like when she first got the shot. It started the day she got the shot, a couple of hours after. She was most comfortable to get Pfizer and went to a specific place to get Pfizer. She had no medications or conditions and that was why she was weirded out. She had good health. This was the first time she has had this. She has had every now and then if she gets up too fast a little thing, not like this. She has not done treatment it because she thought it would dissipate. That is why she was calling. Her friend sent her a link and there were quite a few people experiencing it. She wanted to report it and to see if other have reported it. The adverse events did not result into a visit to Emergency Room or Physician Office.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 37.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness
Clinical narrative: Patient experienced dizziness for 24 hour period following vaccine administration; This is a spontaneous report received from a contactable reporter(s) (Other HCP). A 37-year-old female patient (unknown if pregnant) received bnt162b2 (BNT162B2), intramuscular, administered in arm left, administration date 15Apr2021 12:30 (Lot number: ER8730) at the age of 37 years as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported.  The following information was reported: DIZZINESS (non-serious) with onset 16Apr2021 12:30, outcome "recovered" (17Apr2021), described as "Patient experienced dizziness for 24-hour period following vaccine administration". Therapeutic measures were not taken as a result of dizziness.  Additional information: It was unknown if patient received any other vaccine in four weeks or not. It was unknown if patient received any other medications in two weeks or not. It was unknown if patient had covid prior vaccination or not. It was unknown if patient had known allergies or not. It was unknown if patient had covid tested post vaccination or not. Patient experienced dizziness for 24-hour period following vaccine administration. The case was assessed as non-serious.  No follow-up attempts are possible. No further information is expected.
Sex: U
Vaccine: COVID19
Symptoms: Hypoaesthesia, Peripheral swelling
Clinical narrative: My whole arm was swelling; Getting numb/ I can't feel my left arm/hand; This is a spontaneous report received from contactable reporter(s) (Consumer or other non-healthcare professional). The reporter is the patient. A patient (no qualifiers provided) received bnt162b2 (BNT162B2), administration date 13Apr2021 (Batch/Lot number: Unknown) as dose 2, single for covid-19 immunisation. The patient relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (Dose 1) for Covid-19 immunisation. The following information was reported: PERIPHERAL SWELLING (non-serious) with onset Apr2021, outcome "not recovered", described as "My whole arm was swelling", HYPOAESTHESIA (non-serious) with onset Apr2021, outcome "not recovered", described as "Getting numb/ I can't feel my left arm/hand". Therapeutic measures were taken as a result of peripheral swelling, hypoaesthesia.  Additional information: Patient received second dose of the Pfizer Covid-19 vaccine on 13Apr and after a few days, Patient noticed that whole arm was swelling, and was getting numb. Patient called doctor who put his/her on steroids for a week, and it did help with the swelling while patient was on the steroids, but the swelling and numbness came back. It was disrupting my day to day, since patient cannot feel my left arm/hand. So patient was wondering if anyone else has had a similar reaction to the vaccine. And if they have, what was done to alleviate the issue.  Follow-up (16Jul2021): This follow-up is being submitted to notify that the lot/batch number is not available despite the follow-up attempts made. Follow-up attempts completed. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Headache, Migraine, Musculoskeletal stiffness, Vomiting
Clinical narrative: stiff neck; headache; she got another migraine and went through throwing up again for hours; migraine with vomitting for 10 hours/throwing up; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  An elderly female patient received bnt162b2 (BNT162B2), administered in arm left, administration date 12May2021 (Lot number: EW0173) as dose 2, single for covid-19 immunisation. Relevant medical history included: "Hashimoto's disease" (ongoing), notes: diagnosed 5 years ago; "Fibromyalgia" (ongoing), notes: diagnosed about 15 years ago; "Arthritis" (ongoing), notes: diagnosed about 15 years ago. The patient's concomitant medications were not reported. Vaccination history included: Bnt162b2 (Dose 1, left; Lot: EP6955), administration date: Apr2021, for COVID-19 immunisation. The following information was reported: MUSCULOSKELETAL STIFFNESS (non-serious) with onset 2021, outcome "unknown", described as "stiff neck"; HEADACHE (non-serious) with onset 2021, outcome "unknown", described as "headache"; MIGRAINE (non-serious) with onset 2021, outcome "unknown", described as "she got another migraine and went through throwing up again for hours"; VOMITING (non-serious) with onset 2021, outcome "unknown", described as "migraine with vomitting for 10 hours/throwing up". Therapeutic measures were taken as a result of headache, migraine, vomiting.  Additional information: Reporter states her husband and she got headache and really stiff necks on Day 1, eventually it went away, states it was gone in the morning when they woke up on Day 2, states on day three she ended up throwing up and had a migraine for 10 hours. Caller states on day four husband was fine and she felt good just a headache. Caller states they were supposed to get their second shot on 01May2021, and she got an eye infection in her left eye the day before, gave her a z pack, so she had to wait to get over the infection and had to get second shot, they got the second dose on 12May2021, States again they they both got headache and stiff neck but expected it because it happened the first time. Caller states her husband had extreme fatigue for several days after the second dose, more than normal, he was falling asleep in the chair, caller states she got another migraine and went through throwing up again for hours. States she treated the migraine with Imitrex and got rid of the migraine, states she took Phenergan to stop throwing up, threw it up before it could work. Tylenol did not get rid of her headache, cannot read NDC, Lot and Expiration Dates because it was too small. States she threw the phenergan up before it could even work, NDC, Lot and Expiration Date are unknown. Caller was calling to report symptoms to the COVID-19 vaccine and states that she attempted to treat her headache with Tylenol and it did not work, states she took 2 extra strength Tylenols.  Follow-up attempts completed. No further information is expected.
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Pain
Clinical narrative: experiences aches and pain "all over".; This is a spontaneous report received from contactable reporter(s) (Other HCP and Consumer or other non HCP) for a Pfizer sponsored program.  A 63 year-old female patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) at the age of 63 years as dose number unknown, single for covid-19 immunisation. Relevant medical history included: "Rheumatoid arthritis" (unspecified if ongoing); "was ill for 14 days with high fevers", start date: Nov2020 (unspecified if ongoing); "covid-19 infection" (unspecified if ongoing), notes: admitted to the hospital on 14Nov20 due to covid-19 infection and remained hospitalized for 6 days; "Patient was admitted to the hospital on 14Nov20" (unspecified if ongoing); "received supplemental oxygen while at home" (unspecified if ongoing), notes: experienced complications after hospitalization. The patient's concomitant medications were not reported. Past drug history included: Xeljanz, start date: 26Feb2020, for Rheumatoid arthritis, notes: Dose: 11mg daily, Route of administration: Oral. The following information was reported: PAIN (non-serious), outcome "unknown", described as "experiences aches and pain "all over".".  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Malaise
Clinical narrative: under the weather; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A female patient received bnt162b2 (BNT162B2), administration date 18Apr2021 (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: MALAISE (non-serious), outcome "unknown", described as "under the weather".  Additional Information: Caller mentioned that she received her 1st dose of the Pfizer COVID vaccine on 18Apr2021. She was supposed to receive her 2nd dose on 9May2021 but was rescheduled to 11May2021. She was not able to come in on 11May2021 because she was under the weather. She would like to schedule an appointment.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Sex: M
Vaccine: COVID19
Symptoms: Blood glucose abnormal, Glycosylated haemoglobin, Glycosylated haemoglobin increased, Hyperglycaemia
Clinical narrative: Within 1 week of Covid-19 vaccine, blood sugar was 600-700; Within 1 week of Covid-19 vaccine, a1C was double digit; This is a spontaneous report received from a contactable reporter(s) (Physician).  A male patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose number unknown, single for covid-19 immunisation. Relevant medical history included: "Diabetes" (unspecified if ongoing), notes: Verbatim: Diabetes. The patient's concomitant medications were not reported. The following information was reported: HYPERGLYCAEMIA (non-serious), outcome "unknown", described as "Within 1 week of Covid-19 vaccine, blood sugar was 600-700"; GLYCOSYLATED HAEMOGLOBIN INCREASED (non-serious), outcome "unknown", described as "Within 1 week of Covid-19 vaccine, a1C was double digit". Relevant laboratory tests and procedures are available in the appropriate section.  Additional Context: The report is cross referenced to report ID: # Caller is a physician calling in regards to the Pfizer Covid-19 vaccine. While reporting on another patient, caller reported that there was another case involving a patient that received the Covid-19 vaccine that the caller was a consultant on. Caller reported that he did not know if the patient received the Pfizer Covid-19 vaccine or not. Caller reported that the patient to begin with had diabetes and the patient's A1C was 6.  Caller reported that within 1 week of getting the Covid-19 vaccine, the patient came to the hospital and had a blood sugar of 600 to 700.  Caller reported that the patient's A1C was also in the double digits. Caller declined to complete report.  Caller reported that he did not know if the patient received the Pfizer Covid-19 vaccine or another vaccine. Caller reported that he was just consulted in the ICU to treat the patient and didn't know any further information.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 61.0
Sex: M
Vaccine: COVID19
Symptoms: Dysgeusia, Parosmia, SARS-CoV-2 test
Clinical narrative: Chemical and metal taste in mouth; Affected smell to where some things smell terrible; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A 61 year-old male patient received bnt162b2 (BNT162B2), intramuscular, administered in arm left, administration date 22Apr2021 08:00 (Lot number: ER8735) at the age of 61 years as dose 1, single for covid-19 immunisation. Relevant medical history included: "Covid-19", start date: Dec2020 (unspecified if ongoing), notes: He got COVID back  around Dec 2020, which was 5 months ago.; "Hypothyroidism" (unspecified if ongoing). Concomitant medication(s) included: SYNTHROID taken for hypothyroidism; MULTIVITAMINS [VITAMINS NOS].  The following information was reported: DYSGEUSIA (non-serious) with onset 23Apr2021, outcome "not recovered", described as "Chemical and metal taste in mouth"; PAROSMIA (non-serious) with onset 23Apr2021, outcome "not recovered", described as "Affected smell to where some things smell terrible". Relevant laboratory tests and procedures are available in the appropriate section.  Additional information: it was reported that patient did not get sick, but thinks it affected his taste and smell.  He had a very odd taste and smell.  He doesn't know how to describe other than saying it was a  chemical, metal taste and certain things just smell awful.  Coffee, when brewing, smells terrible.  He believes it has been going on around 4 weeks now. Patient took Synthroid at least 10 years. He got COVID back  around Dec 2020, which was 5 months ago. He also take a multivitamin and is pretty healthy. He does not know if it ever returned to normal.  He did not think about it though.  After vaccine, it just got really bad.   No follow-up attempts are possible. No further information is expected.
Age: 72.0
Sex: M
Vaccine: COVID19
Symptoms: Feeling cold, Heat exhaustion, Hyperhidrosis, Laziness, SARS-CoV-2 test negative
Clinical narrative: he has perspiration so bad he has to change under clothes.; He feels lazy. He gets heat; he feels lazy; feeling cold; shake; I'm getting sweat every night.; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A 72 year-old male patient received bnt162b2 (BNT162B2), administration date 02May2021 (Batch/Lot number: unknown) at the age of 72 years as 2nd dose, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (Dose number: 1), for COVID-19 immunization. The following information was reported: HYPERHIDROSIS (non-serious), outcome "not recovered", described as "he has perspiration so bad he has to change under clothes."; HEAT EXHAUSTION (non-serious), outcome "not recovered", described as "He feels lazy. He gets heat"; LAZINESS (non-serious), outcome "not recovered", described as "he feels lazy"; FEELING COLD (non-serious), outcome "not recovered", described as "feeling cold"; TREMOR (non-serious), outcome "not recovered", described as "shake"; HYPERHIDROSIS (non-serious), outcome "not recovered", described as "I'm getting sweat every night.". The events "he has perspiration so bad he has to change under clothes.", "he feels lazy. he gets heat", "he feels lazy", "feeling cold", "shake" and "i'm getting sweat every night." were evaluated at the physician office visit. Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were taken as a result of hyperhidrosis, heat exhaustion, laziness, feeling cold, tremor, hyperhidrosis. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.  Additional information:  He is calling about the second Covid 19 vaccine he received on 02May2021. It is still sometimes affecting him badly. The first Covid 19 vaccine was ok. The second Covid 19 vaccine is a problem for him. He's having perspiration every night since he received the vaccine, 17 days ago. Then he feels lazy. He gets hot when he's doing something faster and if he stops the hotness goes away. One thing, he doesn't shake or feel cold anymore. He was waking up at 3:00AM or 4:00AM feeling cold. But the perspiration he had twice yesterday, once at 12:00AM and once at 2:00AM, he had to change his underwear twice.
Age: 72.0
Sex: M
Vaccine: COVID19
Symptoms: Tremor
Clinical narrative: he has perspiration so bad he has to change under clothes.; He feels lazy. He gets heat; he feels lazy; feeling cold; shake; I'm getting sweat every night.; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A 72 year-old male patient received bnt162b2 (BNT162B2), administration date 02May2021 (Batch/Lot number: unknown) at the age of 72 years as 2nd dose, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (Dose number: 1), for COVID-19 immunization. The following information was reported: HYPERHIDROSIS (non-serious), outcome "not recovered", described as "he has perspiration so bad he has to change under clothes."; HEAT EXHAUSTION (non-serious), outcome "not recovered", described as "He feels lazy. He gets heat"; LAZINESS (non-serious), outcome "not recovered", described as "he feels lazy"; FEELING COLD (non-serious), outcome "not recovered", described as "feeling cold"; TREMOR (non-serious), outcome "not recovered", described as "shake"; HYPERHIDROSIS (non-serious), outcome "not recovered", described as "I'm getting sweat every night.". The events "he has perspiration so bad he has to change under clothes.", "he feels lazy. he gets heat", "he feels lazy", "feeling cold", "shake" and "i'm getting sweat every night." were evaluated at the physician office visit. Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were taken as a result of hyperhidrosis, heat exhaustion, laziness, feeling cold, tremor, hyperhidrosis. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.  Additional information:  He is calling about the second Covid 19 vaccine he received on 02May2021. It is still sometimes affecting him badly. The first Covid 19 vaccine was ok. The second Covid 19 vaccine is a problem for him. He's having perspiration every night since he received the vaccine, 17 days ago. Then he feels lazy. He gets hot when he's doing something faster and if he stops the hotness goes away. One thing, he doesn't shake or feel cold anymore. He was waking up at 3:00AM or 4:00AM feeling cold. But the perspiration he had twice yesterday, once at 12:00AM and once at 2:00AM, he had to change his underwear twice.
Age: 13.0
Sex: M
Vaccine: COVID19
Symptoms: Gait disturbance, Limb discomfort, Malaise, Pain
Clinical narrative: Legs are super heavy; hard to walk; achy body; generally horrible feeling; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 13 year-old male patient received bnt162b2 (BNT162B2), administered in arm right, administration date 17May2021 12:30 (Lot number: EW 0169) at the age of 13 years as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: LIMB DISCOMFORT (non-serious) with onset 18May2021 10:00, outcome "not recovered", described as "Legs are super heavy"; GAIT DISTURBANCE (non-serious) with onset 18May2021 10:00, outcome "not recovered", described as "hard to walk"; PAIN (non-serious) with onset 18May2021 10:00, outcome "not recovered", described as "achy body"; MALAISE (non-serious) with onset 18May2021 10:00, outcome "not recovered", described as "generally horrible feeling".  Additional information: Patient was not covid tested post vaccination. No other vaccine in four weeks. No other medications Two weeks. No covid prior vaccination.  No follow-up attempts are possible. No further information is expected.
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Influenza like illness, Lymphadenopathy, Nervous system disorder, Vaccination site pain
Clinical narrative: throbbing headache; injection site pain; enlarged lymph nodes under left arm; moderate flu like symptoms; difficulty processing things two days later - neurological; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP).  A 60 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), intramuscular, administered in arm left, administration date 14May2021 (Lot number: EW0183) at the age of 60 years as dose 2, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (lot Number:  ER8731, administrator route: Intramuscular, vaccination Location: Left arm, Dose : 01), administration date: 23Apr2021, when the patient was 60 years old, for COVID-19 Immunization. The following information was reported: HEADACHE (non-serious) with onset 16May2021, outcome "recovered" (2021), described as "throbbing headache"; VACCINATION SITE PAIN (non-serious) with onset 16May2021, outcome "recovered" (2021), described as "injection site pain"; LYMPHADENOPATHY (non-serious) with onset 16May2021, outcome "recovered" (2021), described as "enlarged lymph nodes under left arm"; INFLUENZA LIKE ILLNESS (non-serious) with onset 16May2021, outcome "recovered" (2021), described as "moderate flu like symptoms"; NERVOUS SYSTEM DISORDER (non-serious) with onset 16May2021, outcome "recovered" (2021), described as "difficulty processing things two days later - neurological". Therapeutic measures were not taken as a result of headache, vaccination site pain, lymphadenopathy, influenza like illness, nervous system disorder.  Follow-up attempts are completed. No further information is expected.  No follow-up attempts are possible. No further information is expected.
Sex: U
Vaccine: COVID19
Symptoms: Circumstance or information capable of leading to medication error, Overdose
Clinical narrative: gave a vaccine that had not been diluted yet. She stated she gave all 6 doses to the patient.; gave a vaccine that had not been diluted yet. She stated she gave all 6 doses to the patient.; This is a spontaneous report received from a contactable reporter(s) (Pharmacist) for a Pfizer sponsored program (159558).  A patient (no qualifiers provided) received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose number unknown, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: OVERDOSE (non-serious), CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR (non-serious), outcome "unknown" and all described as "gave a vaccine that had not been diluted yet. She stated she gave all 6 doses to the patient.". No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.